Q1 2025
Released May 13, 2025, after the close
10-Q filed May 13, 2025, 43 days after period end · 0000950170-25-070461
Q1 2025 · 10-Q
Revenue—
Net Income-$2.86M-$2.86M N/M vs Q1 2024N/M vs Q4 2024
EPS Diluted-$0.06-$0.06 N/M vs Q1 2024no prior Q4 2024 on file
Operating Income-$3,202,510N/M
Operating Cash Flow-$3,783,661N/M
Free Cash Flowderived-$3,783,661—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2025 | Q1 2024 | Q1 2022 | Q1 2020 |
|---|---|---|---|---|
| Net Income | -$2.86M | -$2.75M | -$4.03M | -$2.71M |
| EPS Diluted | -$0.06 | -$0.06 | -$0.08 | -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medicinova Inc · CIK 1226616 · Engraved from SEC EDGAR